News World first as infant gets personalised CRISPR therapy In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation.
R&D Advancing innovation in life sciences R&D and Quality: Towar... This year’s Veeva R&D and Quality Summit saw full-house attendance at the Marriott Auditorium Hotel in Madrid.
R&D Case Study: MHRA Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Patients Sponsored Case Study: MHRA and AstraZeneca Agile, responsive regulation helps early breast cancer patients to benefit from a study to potentially improve survival outcomes.
Oncology Sponsored Case Study: MGI and Alacris Theranostics As World Cancer Day approached this year, the increasing focus on precision oncology continued apace.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.